Full Text (PDF)
Case Report

Raktamokshana in Utsangini

Syed Rasool Sufi yan, Veerayya R Hiremath, Shashikala K null

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.



Ophthalmology and Allied Sciences 9(1-2):p 19-23, January-August 2023. | DOI: 10.21088/oas.2454.7816.9123.3

How Cite This Article:

Sufiyan SR, Hiremath VR, Shashikala K, et al. Raktamokshana in Utsangini. Ophthalmol Allied Sci. 2023;9(1):19-23.

Timeline

Received : May 01, 2023         Accepted : June 06, 2023          Published : July 30, 2023

Abstract

Introduction: Chalazia (plural of chalazion), are the most common inflammatory lesions of the eyelid. They are typically slowly enlarging; non-tender eyelid nodules present in the sub tarsal conjunctiva of the eye lids. Chalazia are typically benign and self-limiting, caused by inflammation and obstruction of sebaceous glands of the eyelids, also called as meibomian cyst. It can be correlated with Utsangini which is the nodular growth like swelling outside eyelids and with its opening present inside due to the vitiation of the tridoshas. The treatment for Utsangini described by the Acharya is Chedana, Bhedana, Lekhana and Shodhana. Raktamokshana with Jalouka is one of the types of Shodhana described by Acharya’s has been inculcated in this study.

Case Report: A 60 year female presented with the complaints of itching, swelling in the right upper eyelid along with redness since 1 month, was treated with Jaloukavacharana. Marked improvement with reduced itching, redness and decreased swelling was noted.

Conclusion: Raktamoshana with Jaloukavacharana is easy, economical, effective in the management of Utsangini


References

  • 1.   • Chaudhari Z, Vanathi M. Postgraduate of ophthalmology. 1st ed. Jaypee Brothers Publishers; 2012. p. 1352.
  • 2.   • Jordan GA, Beier K. Chalazion [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [updated 2022 Aug 1• Das AV, Dave TV. Demography and clinical features of chalazion among patients seen at a multi-tier eye care network in India: an electronic medical records driven big data analysis report. Clin Ophthalmol. 2020;14:2163-8.
  • 3.   • Chaudhari Z, Vanathi M. Postgraduate of ophthalmology. 1st ed. Jaypee Brothers Publishers; 2012. p. 1352.
  • 4.   • Sushruta. Sushruta Samhita (Nibandhasangraha Dalhana krit). Acharya VJT, editor. Varanasi: Chaukambha Sanskrit Sansthan; 2013. Uttara Sthana, ch 3, ver 9; p. 599.
  • 5.   • Madhavakara. Madhav nidana. Murthy KRS, translator. Reprint ed. Varanasi: Chaukamba Samskrit Samstana; 2011. Chapter 59/76; p. 213.
  • 6.   • Vagbhata. Astanga hridayam. Paradakara HSS, editor. Reprint ed. Varanasi: Chaukambha Sanskrit Sansthan; 2012. Uttarasthana 8/12; p. 505.
  • 7.   • Sushruta. Sushruta Samhita (Nibandhasangraha Dalhana krit). Acharya VJT, editor. Varanasi: Chaukambha Sanskrit Sansthan; 2013. Uttara Sthana, ch 3, ver 9; p. 599. (Videha vachana).
  • 8.   • Sushruta. Sushruta Samhita (Nibandhasangraha Dalhana krit). Acharya VJT, editor. Varanasi: Chaukambha Sanskrit Sansthan; 2013. Uttara Sthana, ch 8, ver 7; p. 610.
  • 9.   • Agnivesha. Charaka samhita. Aacharya VJT, editor. 2nd ed. Varanasi: Chaukhamba Sanskrit Sansthan; 2014. Sutra Sthana, ch 16, ver 20-21; p. 97.
  • 10.   • Sushruta. Sushruta Samhita (Nibandhasangraha Dalhana krit). Acharya VJT, editor. Varanasi: Chaukambha Sanskrit Sansthan; 2013. Uttara Sthana, ch 13, ver 19; p. 57.
  • 11.   • Jordan GA, Beier K. Chalazion [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 [updated 2022 Aug 1• Sig AK, Guney M, Uskudar Guclu A, Ozmen E. Medicinal leech therapy-an overall perspective. Integr Med Res. 2017;6(4):337-43.

About this article


Cite this article

Sufiyan SR, Hiremath VR, Shashikala K, et al. Raktamokshana in Utsangini. Ophthalmol Allied Sci. 2023;9(1):19-23.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.



Received Accepted Published
May 01, 2023 June 06, 2023 July 30, 2023

DOI: 10.21088/oas.2454.7816.9123.3

Keywords

Utsangini

Article Level Metrics

Last Updated

Sunday 26 July 2026, 11:19:48 (IST)


577

Accesses

9
66
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received May 01, 2023
Accepted June 06, 2023
Published July 30, 2023

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.



Access this article



Share